Wednesday, February 10, 2010, 7:48pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

King Pharmaceuticals Inc. (KG)

At 5:02AM SGT: 11.44 USD   0.00 (0.00%)  
 MORE ON KG 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 KING PHARMACEUTICALS (NYSE:KG) Delayed quote dataEdit
Last Trade:11.44 USD
Trade Time:5:02AM SGT
Change: 0.00 (0.00%)
Prev Close:11.44
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:12.88
Day's Range:N/A - N/A
52wk Range:5.86 - 13.20
Volume:0
Avg Vol (3m):2,859,660
Market Cap:2.84B
P/E (ttm):N/A
EPS (ttm):-1.93
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add KG to Portfolio   Download Data

 HEADLINES 
•King Pharmaceuticals Appoints Two New Members to Its Board of Directors
Marketwire (Wed 5:55am)
•King Launches PainBalance(R): Educational Initiative to Help Reduce the Burden of Pain
PR Newswire (Wed, Feb 3)
•Coverage initiated on King Pharms by Jefferies & Co
Briefing.com (Tue, Feb 2)
•Why Pharma Is Pushing Its Drug Pushers Out
at Minyanville.com (Fri, Jan 22)
•UPDATE - King Pharmaceuticals reviews animal health unit
at Reuters (Sat, Jan 16)
•KING PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Fri, Jan 15)
•King Pharmaceuticals To Present At J.P. Morgan Healthcare Conference
Business Wire (Wed, Jan 6)
•King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results
at Seeking Alpha (Thu, Dec 31)
•[video] Stealth Generic Drug Play: 1 Minute Trade
at TheStreet.com (Fri, Dec 11)
•ZymoGenetics claims court win versus King
at bizjournals.com (Fri, Dec 11)
•KING PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Dec 10)
More Headlines for KG...
 ANALYST 
EPS Est (next year) (Dec-09) :1.08
EPS Est (in 2 years) (Dec-10) :1.02
Avg Rec (current)*:1.8
PEG Ratio:1.72
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
King Pharmaceuticals, Inc. research and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices